Table 1 Descriptive characteristics of DC cohort HIV clinical sites, Pre and Peri-pandemic (N = 14 Clinics)
Baseline characteristics | n (%) |
|---|---|
Clinic Type | |
Community-based | 7 (50%) |
Hospital-based | 7 (50%) |
Ryan White Clinic | |
Yes | 9 (64%) |
No | 5 (36%) |
Clinic Size | n |
Overall patients cared for at all clinics | 16,192 |
Patients enrolled in DC Cohort | 11,469 |
Use of telehealth1 prior to the pandemic | |
< 1 year | 5 (62.5%) |
1–5 years | 3 (37.5%) |
Number of HIV Care Providers Pre-Pandemic | median (IQR) |
HIV clinical providers | 5.5 (5–14) |
Case managers | 2 (1–4) |
Eligibility specialists | 1 (0–3) |
Peer navigators | 0.5 (0–2.5) |
Community health workers | 0 (0–2) |
Pharmacists | 0 (0–1) |
Pandemic clinic services | |
Clinic closure during the pandemic | |
No | 12 (85.7%) |
Yes | 2 (14.3%) |
SARS-CoV-2 Testing on Site | |
Yes | 11 (78.6%) |
No | 3 (21.4%) |
Type of SARS-CoV-2 Testing | |
PCR test | 11 (78.6%) |
Rapid antigen test | 7 (50%) |
Antibody test | 5 (35.7) |
Length of time to receive SARS-CoV-2 test results | |
2–3 days | 7 (63.6%) |
Next day | 3 (27.3%) |
Same day | 1 (9.1%) |
COVID Vaccine Administration at Clinic | |
Yes | 11 (78.6%) |
No | 3 (21.4%) |